News & Publications

On this page, you can find our publications in different disease areas and all the latest news and updates related to Porsolt.

In person visits and attending key conferences are key to maintaining strong relationships with Porsolt‘s valued clients and collaborators. Sebastien Breche and …

Porsolt has unique expertise and capabilities to evaluate acute and delayed #emesis by implanting telemetry devices that can track the occurrence of …

BIO US 2023

Guillaume Froget and David Pushett are having an extremely busy #BIO2023 conference this week in Boston with a full schedule of productive …

Porsolt logo

A productive time at Porsolt this week for our mid-year Sales and Marketing meeting, with #workshops and #strategizing, together with some nice …

Central Nervous System

“Early stage GLP safety assessment can be a deal breaker” will be presented by Kendall Walker PhD. from Porsolt this week at …

Porsolt logo

Quality Assurance is an integral part of the drug development process and is crucial for GLP compliance. Porsolt has continually maintained GLP status …

AACR 2023

Successful meeting so far for Porsolt at the #aacr2023 conference.

lungs

Coughing is one of the most common symptoms associated with respiratory diseases such as asthma, chronic bronchitis, and pulmonary fibrosis. Porsolt has …

Porsolt’s newly developed Real Time PCR (qPCR) capabilities can be used to detect key molecular pathway modulations at early stages and quantitate …

Porsolt logo

Porsolt is vigorously continuing our research and collaborations in 2023 with our most recent publication in partnership with COMETE INSERM/UNICAEN UMR-S1075 on …

Porsolt

Z.A. de Glatigné
53940 Le Genest-Saint-Isle, France
Telephone +33 2 43 69 36 07

LinkedIn
Legal Notice

Any questions or concerns ?

CONTACT US